I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 48 050 VND -0.93%
Market Cap: 7.4T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Imexpharm Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imexpharm Corp
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
I
Imexpharm Corp
VN:IMP
Operating Income
â‚«335.4B
CAGR 3-Years
13%
CAGR 5-Years
16%
CAGR 10-Years
14%
H
HaTay Pharmaceutical JSC
VN:DHT
Operating Income
â‚«72B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
4%
C
Cuu Long Pharmaceutical JSC
VN:DCL
Operating Income
â‚«70.7B
CAGR 3-Years
15%
CAGR 5-Years
43%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Operating Income
â‚«189.9B
CAGR 3-Years
2%
CAGR 5-Years
-18%
CAGR 10-Years
2%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Operating Income
â‚«811.6B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
2%
T
Traphaco JSC
VN:TRA
Operating Income
â‚«282.7B
CAGR 3-Years
-21%
CAGR 5-Years
-5%
CAGR 10-Years
3%
No Stocks Found

Imexpharm Corp
Glance View

Market Cap
7.4T VND
Industry
Pharmaceuticals

Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

IMP Intrinsic Value
27 228.06 VND
Overvaluation 43%
Intrinsic Value
Price
I

See Also

What is Imexpharm Corp's Operating Income?
Operating Income
335.4B VND

Based on the financial report for Sep 30, 2024, Imexpharm Corp's Operating Income amounts to 335.4B VND.

What is Imexpharm Corp's Operating Income growth rate?
Operating Income CAGR 10Y
14%

Over the last year, the Operating Income growth was -6%. The average annual Operating Income growth rates for Imexpharm Corp have been 13% over the past three years , 16% over the past five years , and 14% over the past ten years .

Back to Top